Featured Firms
Presented by BigVoodoo
Catherine Nyarady, a partner at Paul, Weiss, Rifkind, Wharton & Garrison, writes that there is little doubt that MedImmune will create a flurry of increased declaratory judgment actions challenging patents - including between parties who had seemingly resolved their disputes. How such actions are framed (contract versus patent) and the specific language of the license agreement are clearly important. However, the long-term impact of the MedImmune decision remains to be seen.
February 01, 2007 at 12:00 AM
1 minute read
Presented by BigVoodoo
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS